ストックスクリーナーアプリを入手
66.28
2.74%
1.647
前日終値:
$64.63
開ける：
$64.04
24時間の取引高:
365.22K
Relative Volume:
0.49
時価総額：
$4.78B
収益：
$58.89M
当期純損益:
$-240.88M
株価収益率:
-21.38
EPS:
-3.1
ネットキャッシュフロー:
$-239.96M
1週間 パフォーマンス:
+2.25%
1か月 パフォーマンス:
+13.85%
6か月 パフォーマンス:
+120.38%
1年 パフォーマンス:
+52.61%
1日の値動き範囲:
$63.77
$67.31
1週間の範囲:
$62.91
$68.30
52週間の値動き範囲:
$19.45
$68.45
Kymera Therapeutics Inc Stock (KYMR) Company Profile
名前
Kymera Therapeutics Inc
セクター
電話
857-285-5314
住所
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN
KYMR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KYMR
Kymera Therapeutics Inc
|
66.39 | 4.65B | 58.89M | -240.88M | -239.96M | -3.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.01 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.11 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.15 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
921.89 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.22 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kymera Therapeutics Inc Stock (KYMR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-03 | 再開されました | Guggenheim | Buy |
| 2025-10-24 | 繰り返されました | B. Riley Securities | Buy |
| 2025-10-21 | 開始されました | Mizuho | Outperform |
| 2025-09-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-09-17 | 開始されました | Barclays | Overweight |
| 2025-09-16 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-07-30 | 再開されました | B. Riley Securities | Buy |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-06-03 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2025-06-03 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-06-02 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-05-20 | 再開されました | Stifel | Buy |
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2024-12-10 | 開始されました | BTIG Research | Buy |
| 2024-12-06 | 開始されました | BMO Capital Markets | Market Perform |
| 2024-12-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-11-18 | 開始されました | Stephens | Overweight |
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
| 2024-08-26 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2024-04-22 | 開始されました | Oppenheimer | Outperform |
| 2024-02-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-01-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-19 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-06-30 | 開始されました | Truist | Buy |
| 2023-05-05 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-12-06 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-11-08 | 開始されました | Raymond James | Mkt Perform |
| 2022-08-15 | 開始されました | Jefferies | Buy |
| 2022-08-03 | 開始されました | Goldman | Buy |
| 2022-07-20 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-04-28 | 開始されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | JP Morgan | Neutral |
| 2022-02-10 | 開始されました | Wells Fargo | Overweight |
| 2021-09-30 | 開始されました | B. Riley Securities | Neutral |
| 2021-09-30 | 開始されました | Stifel | Buy |
| 2021-09-10 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-05-21 | 開始されました | UBS | Buy |
| 2021-04-14 | 開始されました | Berenberg | Buy |
| 2020-12-04 | 開始されました | H.C. Wainwright | Buy |
| 2020-09-15 | 開始されました | BofA Securities | Neutral |
| 2020-09-15 | 開始されました | Cowen | Outperform |
| 2020-09-15 | 開始されました | Guggenheim | Buy |
| 2020-09-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Kymera Therapeutics Inc (KYMR) 最新ニュース
Will Kymera Therapeutics Inc. stock benefit from infrastructure spendingWeekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com
Kymera at Jefferies Conference: Targeted Protein Degradation Focus - Investing.com India
Kymera at Jefferies Conference: Targeted Protein Degradation Focus By Investing.com - Investing.com Canada
Is Kymera Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
Kymera Therapeutics (NASDAQ:KYMR) Hits New 52-Week HighStill a Buy? - MarketBeat
Behavioral Patterns of KYMR and Institutional Flows - news.stocktradersdaily.com
Candriam S.C.A. Invests $6.73 Million in Kymera Therapeutics, Inc. $KYMR - MarketBeat
How analysts rate Kymera Therapeutics Inc. stock todayJuly 2025 Highlights & Expert Approved Momentum Ideas - newser.com
Stifel reiterates Buy rating on Kymera Therapeutics stock ahead of December data - Investing.com Canada
Is Kymera Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
Why Kymera Therapeutics Inc. stock could outperform in 2025Trade Risk Summary & Weekly Top Performers Watchlists - Fundação Cultural do Pará
How to read the order book for Kymera Therapeutics Inc.Bear Alert & Low Risk High Reward Trade Ideas - newser.com
Kymera at TD Cowen Summit: Strategic Moves in Immunology By Investing.com - Investing.com Canada
What analysts say about Kymera Therapeutics Inc stockMoving Average Crossovers & Subscribe for Free Weekly Winners - earlytimes.in
What valuation multiples suggest for Kymera Therapeutics Inc. stock2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
What drives Kymera Therapeutics Inc stock priceStock Liquidity Analysis & Free Rapid Growing Investment Returns - earlytimes.in
Kymera Therapeutics stock hits 52-week high at 64.0 USD By Investing.com - Investing.com Philippines
Kymera added to Citi catalyst watch list on atopic dermatitis asset data readout - MSN
Kymera at Stifel Conference: Strategic Insights on Drug Development By Investing.com - Investing.com UK
Kymera Therapeutics stock hits 52-week high at 64.0 USD - Investing.com
Kymera Therapeutics soars 35% on positive phase 1 results for oral STAT6 degrader KT-621 - MSN
Pattern recognition hints at Kymera Therapeutics Inc. upsideAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Transcript : Kymera Therapeutics, Inc. Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 11 - MarketScreener
What is HC Wainwright's Forecast for KYMR FY2025 Earnings? - MarketBeat
Equities Analysts Set Expectations for KYMR FY2025 Earnings - MarketBeat
Kymera Therapeutics (NASDAQ:KYMR) Upgraded at Wall Street Zen - MarketBeat
Kymera Therapeutics (KYMR) Gets a Buy from RBC Capital - The Globe and Mail
Kymera Therapeutics’ Earnings Call Highlights Growth and Challenges - MSN
Wells Fargo & Company Forecasts Strong Price Appreciation for Kymera Therapeutics (NASDAQ:KYMR) Stock - MarketBeat
Kymera Therapeutics Reports Q3 2025 Financial Results - MSN
HC Wainwright & Co. Maintains Kymera Therapeutics (KYMR) Buy Recommendation - MSN
Kymera upped to overweight by Wells Fargo on upcoming data - MSN
Barclays Maintains Kymera Therapeutics (KYMR) Overweight Recommendation - Nasdaq
Kymera Therapeutics (KYMR): Barclays Raises Price Target to $70. - GuruFocus
Kymera Therapeutics (NASDAQ:KYMR) Releases Quarterly Earnings Results - MarketBeat
Wells Fargo Raises Price Target for Kymera Therapeutics (KYMR) | - GuruFocus
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2025 Earnings Call Transcript - Insider Monkey
Kymera Therapeutics stock price target raised to $84 from $70 at H.C. Wainwright - Investing.com Canada
KYMR Stock: HC Wainwright & Co. Raises Price Target to $84 | KYM - GuruFocus
10 Analysts Have This To Say About Kymera Therapeutics - Benzinga
Decoding Kymera Therapeutics Inc (KYMR): A Strategic SWOT Insigh - GuruFocus
Is Kymera Therapeutics Inc. stock attractive for ETFsJuly 2025 Patterns & Capital Efficiency Focused Ideas - newser.com
Kymera Therapeutics, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:KYMR) 2025-11-04 - Seeking Alpha
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com
Kymera Therapeutics Inc (KYMR) 財務データ
収益
当期純利益
現金流量
EPS
Kymera Therapeutics Inc (KYMR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Mainolfi Nello | Chief Executive Officer |
Oct 29 '25 |
Sale |
60.99 |
30,000 |
1,829,737 |
660,482 |
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):